N-Arachidonoyl dopamine
From Self-sufficiency
| N-Arachidonoyl dopamine | |
|---|---|
| File:NADA.png | |
| (5Z,8Z,11Z,14Z)-N-[2-(3,4-dihydroxyphenyl)-ethyl]icosa-5,8,11,14-tetraenamide | |
| Other names NADA | |
| style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
| CAS number | 199875-69-9 |
| PubChem | 5282105 |
| SMILES | Script error: No such module "collapsible list". |
| style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
| Molecular formula | C28H41NO3 |
| Molar mass | 439.63 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
N-Arachidonoyl dopamine (NADA) is an endocannabinoid which acts as an agonist of the CB1 receptor[1] and the transient receptor potential V1 (TRPV1) ion channel. Its discovery was described in 2002 by an academic research group from Italy and the USA. It was found in the brain of rats, with especially high concentrations in the hippocampus, cerebellum and striatum. It activates the TRPV1 channel with an EC50 of approximately of 50 nM. The high potency makes it the putative endogenous TRPV1 agonist.[2]
See also
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />External links
- General information about NADA.
